Page last updated: 2024-11-02

oxaprozin and Osteoarthritis, Knee

oxaprozin has been researched along with Osteoarthritis, Knee in 1 studies

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, SZ1
Dedhiya, SD1
Bocanegra, TS1
Fort, JG1
Kuss, ME1
Rush, SM1

Trials

1 trial available for oxaprozin and Osteoarthritis, Knee

ArticleYear
Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee.
    Clinical therapeutics, 1999, Volume: 21, Issue:1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Female; Humans; Male; Middle Aged; Nabumet

1999